Received May 18, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Engerix-B pediatric dose administered to a 66-year-old male patient.; This non-serious case was reported by a consumer via call center representative and described the occurrence of adult use of a child product in a 66-year-old male patient who received HBV (Engerix B pediatric) (expiry date 24-SEP-2027) for prophylaxis. On 12-MAY-2026, the patient received Engerix B pediatric. On 12-MAY-2026, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: Engerix-B pediatric dose administered to a 66-year-old male patient.). The outcome of the adult use of a child product was not applicable. Additional Information: GSK Receipt Date: 13-MAY-2026 The batch number was not provided upon follow- up with the reporter.